What It Is:

ClinOps GPS is Reverba’s clinical engagement model for improving recruitment, retention, and study execution.

The model combines investigator development, site training and engagement, patient recruitment and pre-qualification, and in-trial experience measurement. All programs are delivered through the reverbaBRIDGE platform, enabling coordinated execution and real-time visibility across the trial ecosystem.

Why It Matters:

Recruitment delays, site variability, and participant dissatisfaction slows progress and increases risk. ClinOps GPS helps sponsors address these challenges through a structured engagement model that improves candidate flow, strengthens site responsiveness, and supports a better experience for participants throughout the study. 

How It Works:

ClinOps GPS activates investigators, sites, patients, and advocacy communities through a coordinated engagement model designed to support recruitment, retention, and trial readiness.

Powered by the reverbaBRIDGE platform, these programs connect site engagement, patient outreach, pre-qualification, and trial experience insights to reduce site burden and strengthen participation across the study.

Let’s talk about how ClinOps GPS can accelerate your clinical trials while improving the patient experience.


The Latest

  • What Gets Measured Gets Funded. But Is Patient Engagement Driving Better Outcomes?
    What Gets Measured Gets Funded. But Is Patient Engagement Driving Better Outcomes?

    Patient engagement is being measured more often, but metrics alone do not show why people participate, stay engaged, or report satisfaction. The more important question is what those measures reveal…

  • Why Pharma Is Rethinking Stakeholder Engagement Across the Product Lifecycle
    Why Pharma Is Rethinking Stakeholder Engagement Across the Product Lifecycle

    From trial recruitment to scientific exchange and patient support, stakeholder engagement cuts across clinical development, medical affairs, and commercialization. In partnership with Pharmaceutical Executive, Reverba Global has launched a new…

  • At Patients as Partners EU: From Insight to Measurable, Scalable Impact—What’s Next for Patient Engagement
    At Patients as Partners EU: From Insight to Measurable, Scalable Impact—What’s Next for Patient Engagement

    Key takeaways from Patients as Partners EU on measuring patient engagement, operationalizing patient experience data, scaling engagement programs, and translating patient insight into measurable outcomes.